stevens-johnson syndrome patient received combination chemotherapy gemcitabine, cisplatin, and 5-fu for biliary tract cancer

Stevens-johnson syndrome has been an acute, usually self-limiting disease of the skin and mucous membranes. this case report has presented an evidence of the development stevens - johnson syndrome associated with combination chemotherapy administration of 5fu, gemcitabin and cisplatin in a patient with biliary tract cancer. our case was a 54-year-old woman patient, a case of biliary tract cancer who has developed more severe symptoms of stevens-johnson syndrome. diagnosis has confirmed by skin biopsy of an affected area .the patient has improved with supportive care, and during 25 day occurred recovery. although stevens-johnson syndrome has been a rare toxicity, physicians should pay a special attention to the monitoring of biliary tract cancer patients on combination chemotherapy with 5fu, cisplatin and gemcitabin.